Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

POU6F2 (POU domain, class 6, transcription factor 2)

Identity

Other namesRPF-1 (Retina-derived POU-domain factor-1)
HGNC POU6F2
Location 7p14.1
Location_base_pair Starts at 39012933 and ends at 39470915 bp from pter ( according to hg18-Mar_2006).
Local_order Cen-CDC2L5-RALA-POU6F2-VPS41-AMPH-Tel

DNA/RNA

Note POU6F2, previously named RPF-1 was isolated from a retina cDNA library
 
  modified from http://genome.ucsc.edu/. Exons 1D to 10 of the gene are indicated by the vertical bars.
Description Thirteen exons, including 4 alternative exons 1, encompassing 458 Kb of genomic DNA (exons 1D to 10).
Transcription Representative mRNA: U91935 2159 bases. Alternative splicings: four alternative exons 1; variable skipping of exon 6; variable skipping of both exons 8 and 9; +/- 36 aminoacids at the 5' end of exon 10.

Protein

 
  modified from: http://www.ebi.ac.uk/
Description POU6F2 is a member of a gene family whose products are characterized by the presence of a bipartite DNA-binding domain, consisting of a POU-specific domain and a POU heterodomain, separated by a variable polylinker. Both subdomains contain helix-turn-helix motifs that directly associate with the two components of bipartite DNA-binding sites. In addition, the POU6F2 protein contains a poly-glutamine (poly-Q) domain. Glutamine repeats are evolutionary conserved domains that may act as polar zippers by joining proteins bound to separate DNA segments and thus regulating their activity. POU domain family members are transcriptional regulators, many of which show highly restricted patterns of expression and are known to control cell type-specific differentiation pathways. POU6F2 encodes a deduced 648-amino acid protein. Alternative splicing potentially generates 24 distinct mRNA isoforms coding for proteins with different DNA-binding activity. The most abundant POU6F2 isoforms in human retina have an insertion of an evolutionarily conserved 36-amino acid peptide into the DNA recognition helix of the POU-specific domain. In vitro, the POU domain of POU6F2 lacking the insert binds to a consensus binding site for the product of another gene of the POU family, OCT1, whereas the alternatively spliced POU domain does not.
Expression Immunohistochemical and ribonuclease protection assays showed that in adult mouse Pou6f2 is expressed within the central nervous system, where its expression is restricted to the medial habenula, to a dispersed population of neurons in the dorsal hypothalamus, and to subsets of ganglion and amacrine cells in the retina. In mouse embryo, Pou6f2 expression was detected during the earliest stages of retinal differentiation where it appears to be involved in the initial steps of amacrine and ganglion cell commitment.
RT-PCR analysis of the mouse Pou6f2 gene revealed expression in kidney, adrenal gland, heart, stomach, muscle, and eye, but not in lung or skin, of mouse fetuses at embryonic day (E) 18, and in kidney, heart, muscle, spleen, and ovary, but not in lung, of adult mice.
Localisation nuclear (presumptive).
Function POU-domain family transcription factor (presumptive).
Homology Other POU-domain family genes

Mutations

Note The POU6F2 gene is located within an interval on chromosome 7p14 where loss of heterozygosity (LOH) was detected in a fraction of Wilms tumors (WTs), a kidney malignancy of childhood characterized by highly heterogeneous genetic alterations. By sequencing the POU6F2 gene in 12 WTs showing LOH on chromosome 7p14, 2 germline mutations of possible pathogenic significance were identified.
The finding of the expression of the POU6F2 mouse homolog in both fetal and adult kidney, together with the demonstration of mutations in WT patients, suggest that the gene is a tumor suppressor and is involved in hereditary predisposition to WT.
Germinal In a patient with WT and LOH at chromosome 7p14, a germline 552G-T transversion in exon 5 of the POU6F2 gene, resulting in a gln184-to-his (Q184H) substitution in a glutamine repeat domain, was identified. The patient showed loss of the constitutionally wildtype allele in tumor DNA. Neither the mother nor the father carried this mutation. Marker studies indicated that the deletion in tumor DNA was of maternal origin, suggesting that the identified base change most likely occurred as a de novo germline point mutation on the paternal chromosome.
In a patient with WT showing LOH at chromosome 7p14, a germline C-to-G transversion in the untranslated portion of the alternatively spliced exon 1C of the POU6F2 gene was identified. The mutation was inherited from the unaffected mother.

Implicated in

Entity Wilms tumor, or nephroblastoma
Prognosis good with treatment according to National Wilms Tumor Study Group (NWTSG) or International Society of Paediatric Oncology (SIOP) or Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)
  

External links

Nomenclature
HGNCPOU6F2   21694
Entrez_GenePOU6F2  11281  POU class 6 homeobox 2
Cards
AtlasPOU6F2ID42963ch7p14
GeneCardsPOU6F2
EnsemblPOU6F2 [Search_View]   ENSG00000106536 [Gene_View]  POU6F2 [Vega]
GenatlasPOU6F2
GeneLynxPOU6F2
eGenomePOU6F2
euGene11281
Genomic and cartography
GoldenPathPOU6F2  -  7p14.1   chr7:39012933-39470915 +  7p14.1   [Description]    (hg18-Mar_2006)
EnsemblPOU6F2 - 7p14.1 [CytoView]
NCBIMapview
OMIMDisease map [OMIM]
HomoloGenePOU6F2
Gene and transcription
GenbankAK309700 [ ENTREZ ]
GenbankBC152915 [ ENTREZ ]
GenbankU91935 [ ENTREZ ]
RefSeqNM_007252 [ SRS ]    NM_007252 [ ENTREZ ]
RefSeqAC_000050 [ SRS ]    AC_000050 [ ENTREZ ]
RefSeqAC_000068 [ SRS ]    AC_000068 [ ENTREZ ]
RefSeqAC_000139 [ SRS ]    AC_000139 [ ENTREZ ]
RefSeqNC_000007 [ SRS ]    NC_000007 [ ENTREZ ]
RefSeqNT_007819 [ SRS ]    NT_007819 [ ENTREZ ]
RefSeqNT_079592 [ SRS ]    NT_079592 [ ENTREZ ]
RefSeqNW_001839003 [ SRS ]    NW_001839003 [ ENTREZ ]
RefSeqNW_923240 [ SRS ]    NW_923240 [ ENTREZ ]
CCDSPOU6F2 CCDS - NCBI
AceViewPOU6F2 AceView - NCBI
UnigeneHs.137106 [ SRS ]    Hs.137106 [ NCBI ]     HS137106 [ spliceNest ]
Fast-db4139 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtP78424 [ SRS]    P78424 [ EXPASY ]     P78424 [ INTERPRO ]     P78424 [ UNIPROT ] P78424 [ VarSplice ]
PrositePS00027 HOMEOBOX_1 [ SRS ]    PS00027 HOMEOBOX_1 [ Expasy ]
PrositePS50071 HOMEOBOX_2 [ SRS ]    PS50071 HOMEOBOX_2 [ Expasy ]
PrositePS00035 POU_1 [ SRS ]    PS00035 POU_1 [ Expasy ]
PrositePS00465 POU_2 [ SRS ]    PS00465 POU_2 [ Expasy ]
PrositePS51179 POU_3 [ SRS ]    PS51179 POU_3 [ Expasy ]
InterproIPR001356 Homeobox [ SRS ]    IPR001356 Homeobox [ EBI ]
InterproIPR012287 Homeodomain-rel [ SRS ]    IPR012287 Homeodomain-rel [ EBI ]
InterproIPR013847 POU [ SRS ]    IPR013847 POU [ EBI ]
InterproIPR000327 POU_specific [ SRS ]    IPR000327 POU_specific [ EBI ]
CluSTrP78424
PfamPF00046 Homeobox [ SRS ]    PF00046 Homeobox [ Sanger ]    pfam00046 [ NCBI-CDD ]
PfamPF00157 Pou [ SRS ]    PF00157 Pou [ Sanger ]    pfam00157 [ NCBI-CDD ]
SmartSM00389 HOX [EMBL]
SmartSM00352 POU [EMBL]
ProdomPD000010 Homeobox[INRA-Toulouse]
ProdomP78424 PO6F2_HUMAN [ Domain structure ]   P78424 PO6F2_HUMAN  [ sequences sharing at least 1 domain ]
ProdomPD000010[INRA-Toulouse]
ProdomP78424 PO6F2_HUMAN [ Domain structure ]   P78424 PO6F2_HUMAN  [ sequences sharing at least 1 domain ]
BlocksP78424
HPRD10162
Protein Interaction databases
DIPP78424
IntActP78424
Polymorphism : SNP, mutations, diseases
OMIM601583;609062    [ map ]   
GENECLINICS601583;609062
SNPPOU6F2 [dbSNP-NCBI]  
SNPNM_007252 [SNP-NCI]  
SNPPOU6F2 [GeneSNPs - Utah]  POU6F2] [HGBASE - SRS]
HAPMAPPOU6F2 [HAPMAP]  
HGMDPOU6F2
Genetic AssociationPOU6F2
CDC HuGEPOU6F2
General knowledge
Family BrowserPOU6F2 [UCSC Family Browser]
SOURCENM_007252
SMDHs.137106
SAGEHs.137106
GOtranscription factor activity [Amigo]  transcription factor activity
GOnucleus [Amigo]  nucleus
GOregulation of transcription, DNA-dependent [Amigo]  regulation of transcription, DNA-dependent
GOtranscription from RNA polymerase II promoter [Amigo]  transcription from RNA polymerase II promoter
GOganglion mother cell fate determination [Amigo]  ganglion mother cell fate determination
GOcentral nervous system development [Amigo]  central nervous system development
GOvisual perception [Amigo]  visual perception
GOsequence-specific DNA binding [Amigo]  sequence-specific DNA binding
PubGenePOU6F2
TreeFamPOU6F2
CTD11281 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbePOU6F2 Related clones (RZPD - Berlin)
PubMed
PubMed5 Pubmed reference(s) in Entrez

Bibliography

Retina-derived POU-domain factor-1: a complex POU-domain gene implicated in the development of retinal ganglion and amacrine cells.
Zhou H, Yoshioka T, Nathans J
The Journal of neuroscience : the official journal of the Society for Neuroscience. 1996 ; 16 (7) : 2261-2274.
PMID 8601806
 
The virtuoso of versatility: POU proteins that flex to fit.
Phillips K, Luisi B
Journal of molecular biology. 2000 ; 302 (5) : 1023-1039.
PMID 11183772
 
Refinement within single yeast artificial chromosome clones of a minimal region commonly deleted on the short arm of chromosome 7 in Wilms tumours.
Perotti D, Testi MA, Mondini P, Pilotti S, Green ED, Pession A, Sozzi G, Pierotti MA, Fossati-Bellani F, Radice P
Genes, chromosomes & cancer. 2001 ; 31 (1) : 42-47.
PMID 11284034
 
Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14.
Perotti D, De Vecchi G, Testi MA, Lualdi E, Modena P, Mondini P, Ravagnani F, Collini P, Di Renzo F, Spreafico F, Terenziani M, Sozzi G, Fossati-Bellani F, Radice P
Human mutation. 2004 ; 24 (5) : 400-407.
PMID 15459955
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written06-2005Daniela Perotti, Luisa Doneda, Paolo Radice
U.O.4 Genetic susceptibility to cancer, Istituto Nazionale Tumori, Via Venezian, 1, 20133 Milan, Italy

Citation

This paper should be referenced as such :
Perotti D, Doneda L, Radice P . POU6F2 (POU domain, class 6, transcription factor 2). Atlas Genet Cytogenet Oncol Haematol. June 2005 .
URL : http://AtlasGeneticsOncology.org/Genes/POU6F2ID42963ch7p14.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Sun Nov 9 19:45:44 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.